SCHEMBL16257589

SCHEMBL16257589

Cc1c(Nc2ccc3ccccc3c2)ncnc1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 3/20 0.48
CSNK2A1 P68400 3/20 0.48
FYN P06241 1/20 0.48
SRC P12931 1/20 0.48
NPC1 O15118 4/20 0.48
RAB9A P51151 4/20 0.48
MAPT P10636 4/20 0.48
MAPK1 P28482 2/20 0.48
MKNK1 Q9BUB5 1/20 0.48
DHODH Q02127 1/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
CYP3A4 P08684 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ASIC3 Q9UHC3 1/20 0.44
IGF1R P08069 1/20 0.43
EGFR P00533 1/20 0.43
GRM4 Q14833 1/20 0.42
CSNK2B P67870 1/20 0.42
MEN1 O00255 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16257514 0.87 KDM4E (0.46) FYNSRCMAPK1EGFRKDM4E
SCHEMBL16257513 0.87 CSF1R (0.45) NPC1RAB9AMAPTMAPK1ALDH1A1
SCHEMBL16257609 0.86 CSF1R (0.47) NPC1RAB9AMAPTMAPK1ALDH1A1
SCHEMBL16257511 0.84 DHODH (0.55) CSNK2A2CSNK2A1FYNSRCNPC1
SCHEMBL16257576 0.81 ANO1 (0.49) IGF1REGFR
SCHEMBL15033668 0.80 KMO (0.58) NPC1RAB9AHSD17B10EGFRGRM4
SCHEMBL16257563 0.76 ALDH1A1 (0.38) CSNK2A2CSNK2A1MAPTMAPK1ALDH1A1
SCHEMBL14306362 0.76 LMNA (0.58) CSNK2A2CSNK2A1DHODHALDH1A1CYP3A4
SCHEMBL16257590 0.74 KIT (0.50) CSNK2A1DHODHGRM4
SCHEMBL16257512 0.73 EGFR (0.48) CSNK2A2CSNK2A1MAPTDHODHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946218-B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US disclosed
EP-2569295-B1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed